One would suspect that there is a lot more to come out in the wash here. Most investors have paid well over the 0.01 that management and their associates get their share for. IMO DYOR
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025